We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
-2.89%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.17B
AUM Growth
-$39.3M
(-1.8%)
Cap. Flow
+$39.3M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
744
New
50
Increased
150
Reduced
186
Closed
36
Avg Time Held
3.2
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$31.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$14.3M |
| 3 |
Zoetis
ZTS
|
+$12.7M |
| 4 |
Walmart Inc
WMT
|
+$12.1M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$9.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$22.1M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$10.6M |
| 3 |
PNC Financial Services
PNC
|
+$9.85M |
| 4 |
O'Reilly Automotive
ORLY
|
+$7.77M |
| 5 |
Verisk Analytics
VRSK
|
+$6.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.46% |
| 2 | Miscellaneous | 14.13% |
| 3 | Financials | 13.51% |
| 4 | Healthcare | 11.86% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Agilent Technologies
A
$48.6B
| $6.24M | 0.29% |
55,808
+33,745
| +153% | +$4.04M |
2015 Q4
31 quarters
|
|
77
Union Pacific
UNP
$171B
| $6.15M | 0.28% |
30,185
-1,835
| -6% | -$400K |
2013 Q2
41 quarters
|
|
78
PepsiCo
PEP
$179B
| $6.13M | 0.28% |
36,183
+3,007
| +9% | +$546K |
2013 Q2
41 quarters
|
|
79
Eli Lilly
LLY
$1.12T
| $5.83M | 0.27% |
10,852
-71
| -0.7% | -$36.6K |
2014 Q1
38 quarters
|
|
80
Donaldson
DCI
$10.1B
| $5.75M | 0.27% |
96,457
+25,592
| +36% | +$1.58M |
2023 Q2
1 quarter
|
|
81
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
| $5.45M | 0.25% |
25,661
+944
| +4% | +$209K |
2014 Q4
35 quarters
|
|
82
DELISTED
Chart Industries
GTLS
| $5.39M | 0.25% |
31,862
+701
| +2% | +$118K |
2022 Q2
5 quarters
|
|
83
US Bancorp
USB
$91.1B
| $5.19M | 0.24% |
156,915
+55
| +0% | +$2K |
2013 Q2
41 quarters
|
|
84
Vanguard FTSE Emerging Markets ETF
VWO
$122B
| $5.09M | 0.23% |
129,917
+2,721
| +2% | +$111K |
2021 Q1
10 quarters
|
|
85
Invesco QQQ Trust
QQQ
$474B
| $5.07M | 0.23% |
14,151
+773
| +6% | +$287K |
2014 Q4
35 quarters
|
|
86
Advanced Micro Devices
AMD
$868B
| $5.01M | 0.23% |
48,758
-1,755
| -3% | -$191K |
2019 Q1
18 quarters
|
|
87
Atmos Energy
ATO
$28.3B
| $4.91M | 0.23% |
46,329
+253
| +0.5% | +$29.5K |
2019 Q1
18 quarters
|
|
88
Oracle
ORCL
$387B
| $4.55M | 0.21% |
42,945
+63
| +0.1% | +$7.29K |
2013 Q2
41 quarters
|
|
89
Abbott
ABT
$181B
| $4.44M | 0.2% |
45,894
-3,420
| -7% | -$359K |
2013 Q2
41 quarters
|
|
90
Applied Materials
AMAT
$328B
| $4.28M | 0.2% |
30,930
-32
| -0.1% | -$4.59K |
2021 Q4
7 quarters
|
|
91
AbbVie
ABBV
$505B
| $4.13M | 0.19% |
27,700
-2,508
| -8% | -$368K |
2013 Q2
41 quarters
|
|
92
NVIDIA
NVDA
$5.16T
| $4.05M | 0.19% |
93,050
+4,140
| +5% | +$185K |
2021 Q2
9 quarters
|
|
|
93
CVS Health
CVS
$119B
| $3.81M | 0.18% |
54,616
-312,451
| -85% | -$22.1M |
2013 Q2
41 quarters
|
|
94
Analog Devices
ADI
$193B
| $3.55M | 0.16% |
20,279
+18,406
| +983% | +$3.39M |
2019 Q1
18 quarters
|
|
95
iShares Gold Trust
IAU
$61.6B
| $3.12M | 0.14% |
89,207
-202
| -0.2% | -$7.37K |
2015 Q2
33 quarters
|
|
96
Essential Utilities
WTRG
$11.6B
| $3.02M | 0.14% |
87,928
-1,492
| -2% | -$57.8K |
2016 Q1
30 quarters
|
|
97
Thermo Fisher Scientific
TMO
$254B
| $2.91M | 0.13% |
5,744
-27
| -0.5% | -$14.4K |
2013 Q2
41 quarters
|
|
98
Unilever
UL
$142B
| $2.85M | 0.13% |
51,302
-15,508
| -23% | -$896K |
2016 Q2
29 quarters
|
|
99
Pfizer
PFE
$168B
| $2.73M | 0.13% |
82,441
-518
| -0.6% | -$18.3K |
2013 Q2
41 quarters
|
|
100
iShares ESG Aware US Aggregate Bond ETF
EAGG
$5B
| $2.69M | 0.12% |
59,432
+2,097
| +4% | +$97.3K |
2021 Q3
8 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q3 2023 Portfolio in Review
As of Q3 2023, Cambridge Trust held 744 positions worth $2.17B, down 1.8% from $2.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Cambridge Trust's Q3 2023 filing shows 50 new, 150 increased, 186 reduced and 36 closed positions. Its largest new stake was Vanguard Short-Term Treasury ETF: 167,956 shares worth $9.67M. The largest sale was CVS Health, an estimated $22.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Miscellaneous and Financials.
- Cambridge Trust's largest Q3 2023 buy was Vanguard Short-Term Treasury ETF: 167,956 shares worth $9.67M.
- Cambridge Trust added most to iShares 7-10 Year Treasury Bond ETF in Q3 2023, an estimated $31.8M increase.
- Cambridge Trust's biggest Q3 2023 reduction was CVS Health, cutting an estimated $22.1M.
- Cambridge Trust fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $330K.
- Cambridge Trust's ten largest holdings make up 30% of its $2.17B portfolio in Q3 2023.
- Cambridge Trust opened 50 new positions and closed 36 in Q3 2023.
- Cambridge Trust's portfolio value fell 1.8% quarter-over-quarter to $2.17B.
Based on Cambridge Trust's 13F filing for Q3 2023, filed 26 Oct 2023.